These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 25662209

  • 1. Decreased vascularization of retroperitoneal kaposiform hemangioendothelioma induced by treatment with sirolimus explains relief of symptoms.
    Iacobas I, Simon ML, Amir T, Gribbin CE, McPartland TG, Kaufman MR, Calderwood S, Nosher JL.
    Clin Imaging; 2015; 39(3):529-32. PubMed ID: 25662209
    [Abstract] [Full Text] [Related]

  • 2. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.
    Jahnel J, Lackner H, Reiterer F, Urlesberger B, Urban C.
    Klin Padiatr; 2012 Oct; 224(6):395-7. PubMed ID: 23070861
    [No Abstract] [Full Text] [Related]

  • 3. Role of Sirolimus in Advanced Kaposiform Hemangioendothelioma.
    Oza VS, Mamlouk MD, Hess CP, Mathes EF, Frieden IJ.
    Pediatr Dermatol; 2016 Oct; 33(2):e88-92. PubMed ID: 26864138
    [Abstract] [Full Text] [Related]

  • 4. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
    Ji Y, Chen S, Yang K, Xia C, Peng S.
    J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141
    [Abstract] [Full Text] [Related]

  • 5. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns.
    Garcia-Monaco R, Giachetti A, Peralta O, Napoli N, Lobos P, Gioseffi L, Mariani G.
    J Vasc Interv Radiol; 2012 Mar; 23(3):417-22. PubMed ID: 22365299
    [Abstract] [Full Text] [Related]

  • 6. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
    Yao W, Li K, Wang Z, Dong K, Zheng S.
    Pediatr Dermatol; 2020 Jul; 37(4):677-680. PubMed ID: 32212177
    [Abstract] [Full Text] [Related]

  • 7. Sirolimus Treatment of an Infant With Intrathoracic Kaposiform Hemangioendothelioma Complicated by Life-threatening Pleural and Pericardial Effusions.
    Duan L, Renzi S, Weidman D, Waespe N, Chami R, Manson D, Cada M, Carcao M.
    J Pediatr Hematol Oncol; 2020 Jan; 42(1):74-78. PubMed ID: 30044355
    [Abstract] [Full Text] [Related]

  • 8. Rapidly enlarging "bruise" on the back of an infant. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt syndrome.
    Chan S, Cassarino DS.
    JAMA Dermatol; 2013 Nov; 149(11):1337-8. PubMed ID: 24005816
    [No Abstract] [Full Text] [Related]

  • 9. Successful treatment of kaposiform lymphangiomatosis with sirolimus.
    Wang Z, Li K, Yao W, Dong K, Xiao X, Zheng S.
    Pediatr Blood Cancer; 2015 Jul; 62(7):1291-3. PubMed ID: 25598153
    [Abstract] [Full Text] [Related]

  • 10. Sirolimus therapy for kaposiform hemangioendothelioma with long-term follow-up.
    Wang Z, Yao W, Sun H, Dong K, Ma Y, Chen L, Zheng S, Li K.
    J Dermatol; 2019 Nov; 46(11):956-961. PubMed ID: 31489702
    [Abstract] [Full Text] [Related]

  • 11. A case of kaposiform haemangioendothelioma successfully and safely treated with sirolimus.
    Wlodek C, Burt H, Shaw L.
    Clin Exp Dermatol; 2017 Oct; 42(7):825-827. PubMed ID: 28703334
    [No Abstract] [Full Text] [Related]

  • 12. Successful Management of Pancreatic Kaposiform Hemangioendothelioma With Sirolimus: Case Report and Literature Review.
    Wang C, Li Y, Xiang B, Li F, Chen S, Li L, Ji Y.
    Pancreas; 2017 Oct; 46(5):e39-e41. PubMed ID: 28426496
    [No Abstract] [Full Text] [Related]

  • 13. Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
    Ji Y, Chen S, Xiang B, Li K, Xu Z, Yao W, Lu G, Liu X, Xia C, Wang Q, Li Y, Wang C, Yang K, Yang G, Tang X, Xu T, Wu H.
    Int J Cancer; 2017 Aug 15; 141(4):848-855. PubMed ID: 28486787
    [Abstract] [Full Text] [Related]

  • 14. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
    Cashell J, Smink GM, Helm K, Xavier F.
    Pediatr Blood Cancer; 2018 Dec 15; 65(12):e27305. PubMed ID: 30070028
    [Abstract] [Full Text] [Related]

  • 15. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
    Wang Y, Kong L, Sun B, Cui J, Shen W.
    J Craniofac Surg; 2020 Jun 15; 31(4):1074-1077. PubMed ID: 32176003
    [Abstract] [Full Text] [Related]

  • 16. Bone kaposiform hemangioendothelioma: A rare entity dramatically improved by sirolimus.
    Boccara O, Dangien A, Fitoussi F, Ducou Le Pointe H, Coulomb L'Hermine A, Fraitag S, Lorrot M.
    J Paediatr Child Health; 2022 Sep 15; 58(9):1676-1679. PubMed ID: 35138010
    [No Abstract] [Full Text] [Related]

  • 17. A case of sirolimus treatment of kaposiform hemangioendothelioma in the neck.
    Kuwabara Y, Ozeki M, Hira K, Fujisaki H, Ohnishi H.
    Pediatr Int; 2022 Jan 15; 64(1):e15000. PubMed ID: 35289458
    [No Abstract] [Full Text] [Related]

  • 18. Kaposiform haemangioendothelioma in an adult: lack of response to topical sirolimus and response to radiotherapy.
    Der Sarkissian SA, Wong XL, Kossard S, Hong A, Sebaratnam DF.
    Clin Exp Dermatol; 2022 Jan 15; 47(1):192-193. PubMed ID: 34480811
    [Abstract] [Full Text] [Related]

  • 19. The effect of topical sirolimus on superficial Kaposiform haemangioendothelioma.
    Liu YX, Zhang J, Nie XL, Chen YL, Wang ZY, Xu ZG.
    Australas J Dermatol; 2021 May 15; 62(2):e329-e331. PubMed ID: 33216947
    [No Abstract] [Full Text] [Related]

  • 20. Successful treatment of Kaposiform hemangioendothelioma with everolimus.
    Uno T, Ito S, Nakazawa A, Miyazaki O, Mori T, Terashima K.
    Pediatr Blood Cancer; 2015 Mar 15; 62(3):536-8. PubMed ID: 25306933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.